Evidence map›Paper›PMID 35390218›Full record

ArticleBioethics2022

Moving from 'fully' to 'appropriately' informed consent in genomics: The PROMICE framework.

Julian J Koplin, Christopher Gyngell, Julian Savulescu, Danya F Vears

Open access · hybridAbstract read
In one paragraph

Article in Bioethics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Fair Consent Transactions and Ethical Pluralism.The Journal of medicine and philosophy · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Consent for genomic sequencing: a conversation, not just a form.European journal of human genetics : EJHG · 2025
    Article
  12. Article
  13. Should the scope of NIPT be limited by a 'threshold of seriousness'?European journal of human genetics : EJHG · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Julian J KoplinBiomedical Ethics Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Christopher GyngellMelbourne Law School, University of Melbourne, Melbourne, Victoria, Australia.
Julian SavulescuBiomedical Ethics Research Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.ORCID 0000-0003-1691-6403
Danya F VearsMelbourne Law School, University of Melbourne, Melbourne, Victoria, Australia.
The University of Melbourne · AU

Funding

Wellcome Trust 104848/Z/14Wellcome Trust 104848/Z/14/ZWellcome Trust 203132/Z/16/Z
6 · The paper itself

Abstract

Genomic sequencing technologies (GS) pose novel challenges not seen in older genetic technologies, making traditional standards for fully informed consent difficult or impossible to meet. This is due to factors including the complexity of the test and the broad range of results it may identify. Meaningful informed consent is even more challenging to secure in contexts involving significant time constraints and emotional distress, such as when rapid genomic testing (RGS) is performed in neonatal intensive care units. In this article, we propose that informed consent matters not for its own sake, but because obtaining it furthers a range of morally important goals, such as promoting autonomy, well-being, and trust in medicine. These goals form the basis of a new framework [PROmoting Morally Important Consent Ends (PROMICE)] for assessing the ethical appropriateness of various informed consent models. We illustrate this framework with two examples: (a) a tiered and layered consent model for obtaining consent for GS, and (b) consent for RGS in critically ill newborns. We conclude that appropriately-rather than fully-informed consent provides the correct standard for genomic medicine and research.

Indexed as

GenomicsInformed ConsentAgedCritical IllnessHumansInfant, NewbornMoralsautonomygenomicsinformed consentrapid genomic testing

Identifiers

PMID35390218
PMCPMC9321597
OpenAlexW4225876523

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.